Receptor status, proliferating activity, and c-erbB2 oncoprotein. An immunocytochemical evaluation in breast cancer

Ann N Y Acad Sci. 1993 Nov 30:698:167-73. doi: 10.1111/j.1749-6632.1993.tb17205.x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / analysis*
  • Breast Neoplasms / pathology*
  • Carcinoma, Ductal, Breast / pathology*
  • Cell Cycle
  • Cell Division
  • Cell Nucleus / pathology
  • ErbB Receptors / analysis*
  • Female
  • Humans
  • Immunohistochemistry / methods
  • Ki-67 Antigen
  • Lymphatic Metastasis
  • Neoplasm Proteins / analysis
  • Neoplasm Staging
  • Nuclear Proteins / analysis
  • Prognosis
  • Proto-Oncogene Proteins / analysis*
  • Receptor, ErbB-2
  • Receptors, Estrogen / analysis*
  • Receptors, Progesterone / analysis*

Substances

  • Biomarkers, Tumor
  • Ki-67 Antigen
  • Neoplasm Proteins
  • Nuclear Proteins
  • Proto-Oncogene Proteins
  • Receptors, Estrogen
  • Receptors, Progesterone
  • ErbB Receptors
  • Receptor, ErbB-2